These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11200608)

  • 21. [Hyperlipidemia and atheroscolerosis in patients with chronic renal failure in hemodialysis].
    del Rio Vázquez A; Rico Lenza H
    Med Clin (Barc); 1980 Mar; 74(6):239-43. PubMed ID: 7366286
    [No Abstract]   [Full Text] [Related]  

  • 22. Are conventional cardiovascular risk factors predictive of two-year mortality in hemodialysis patients?
    Fleischmann EH; Bower JD; Salahudeen AK
    Clin Nephrol; 2001 Sep; 56(3):221-30. PubMed ID: 11597037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How should hypertension be assessed and managed in hemodialysis patients? Home BP, not dialysis unit BP, should be used for managing hypertension.
    Agarwal R
    Semin Dial; 2007; 20(5):402-5. PubMed ID: 17897244
    [No Abstract]   [Full Text] [Related]  

  • 24. Hyperhomocysteinemia in end stage renal disease: is treatment necessary?
    Snavely J
    Nephrol Nurs J; 2002 Apr; 29(2):155-60; quiz 161-2. PubMed ID: 11997950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Atherosclerosis and hypertriglyceremia in chronic renal failure].
    Lutz W
    Pol Tyg Lek; 1976 Jun; 31(25):1089-91. PubMed ID: 181736
    [No Abstract]   [Full Text] [Related]  

  • 26. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P
    Acta Med Croatica; 2001; 55(4-5):177-86. PubMed ID: 12398021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study on the atherosclerosis mechanism in chronic hemodialysis.
    Kudoh Y; Iimura O
    Jpn Circ J; 1987 Jun; 51(6):631-41. PubMed ID: 3669270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V; Kes P; Reiner Z
    Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chronic kidney failure, hyperproteinemia and vascular risk].
    Rubiés-Prat J
    Med Clin (Barc); 1984 Jun; 83(4):173-5. PubMed ID: 6482569
    [No Abstract]   [Full Text] [Related]  

  • 30. [Complications suffered by dialysis patients. 1. Circulatory diseases].
    Imada A
    Nihon Naika Gakkai Zasshi; 2000 Jul; 89(7):1343-8. PubMed ID: 11032501
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperhomocysteinemia and polymorphisms of the methylenetetrahydrofolate gene in hemodialysis and peritoneal dialysis patients.
    Domenici FA; Vannucchi MT; Simões-Ambrósio LM; Vannucchi H
    Mol Nutr Food Res; 2007 Nov; 51(11):1430-6. PubMed ID: 17966140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease.
    Moinuddin I; Leehey DJ
    Adv Chronic Kidney Dis; 2008 Jan; 15(1):83-96. PubMed ID: 18155113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.
    Wang MC; Tsai WC; Chen JY; Huang JJ
    Am J Kidney Dis; 2005 Mar; 45(3):494-501. PubMed ID: 15754271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The contribution of hypertension to dialysis patient outcomes. A point of view.
    Mailloux LU; Bellucci AG; Napolitano B; Mossey RT
    ASAIO J; 1994; 40(2):130-7. PubMed ID: 8003749
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance.
    Chu PL; Chiu YL; Lin JW; Chen SI; Wu KD
    Blood Purif; 2008; 26(2):213-20. PubMed ID: 18285698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension and dyslipidemia.
    Jazra C
    J Med Liban; 2000; 48(6):364-9. PubMed ID: 11503527
    [No Abstract]   [Full Text] [Related]  

  • 37. [Atherogenic risk factors in chronic renal failure. Clinical significance].
    Grützmacher P
    Fortschr Med; 1991 Jan; 109(1):37-8. PubMed ID: 2022351
    [No Abstract]   [Full Text] [Related]  

  • 38. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
    Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should hyperlipemia of renal failure be treated?
    Ritz E; Augustin J; Bommer J; Gnasso A; Haberbosch W
    Kidney Int Suppl; 1985 Dec; 17():S84-7. PubMed ID: 3867805
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pathology of chronic renal insufficiency treated with repeated hemodialysis].
    de Werra P
    Rev Med Suisse Romande; 1980 May; 100(5):413-7. PubMed ID: 7455466
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.